Back
icad 10K Form
Sell
50
ICAD
icad
Last Price:
1.96
Seasonality Move:
15.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | ICAD/icad Quarterly |
| 2023-11-14 | 10Q | ICAD/icad Quarterly |
| 2023-08-11 | 10Q | ICAD/icad Quarterly |
| 2023-05-15 | 10Q | ICAD/icad Quarterly |
| 2022-11-14 | 10Q | ICAD/icad Quarterly |
| 2022-08-15 | 10Q | ICAD/icad Quarterly |
Receive ICAD News And Ratings
See the #1 stock for the next 7 days that we like better than ICAD
ICAD Financial Statistics
Sales & Book Value
| Annual Sales: | $17.32M |
|---|---|
| Cash Flow: | $-1.56M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.11 |
| Price / Book: | 1.77 |
Profitability
| EPS (TTM): | -0.14000 |
|---|---|
| Net Income (TTM): | $-2.71M |
| Gross Margin: | $14.79M |
| Return on Equity: | -8.61% |
| Return on Assets: | -6.65% |
icad Earnings Forecast
Key icad Financial Ratios
- The Gross Profit Margin over the past 37 years for ICAD is 85.37%.
- The Selling, General & Administrative Expenses for ICAD have been equal to 98.53% of Gross Profit Margin.
- The Research & Development expenses have been 29.80% of Revenue.
- The Interest Expense is -0.33% of Operating Income.
- The Net Earning history of ICAD is -27.99% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 20 years.
icad Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | ICAD |
| CUSIP: | 44934S |
| Website: | icadmed.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.02 |
| Quick Ratio: | 3.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |